Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

213
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
213
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

10.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

485
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
485
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

141
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
141

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Mobile Health Platform for Heart Failure Self-Management: Feasibility Study on Patient Engagement, Acceptance, and Potential Health Outcomes.

JMIR formative research·2026
Same author

Artificial intelligence in healthcare: a qualitative study exploring consumer perspectives.

BMC medical ethics·2026
Same author

Co-design of Lifestyle6, a digital tool targeting multiple health behaviour changes for cancer risk reduction and early detection support.

PloS one·2026
Same author

Most digital psychological interventions for chronic pain fail to measure all 4 dimensions of the quadruple aim of value-based health care: a scoping review.

Pain·2026
Same author

Digitising Medical Nutrition Therapy in Gestational Diabetes: A Multisite Pilot Study.

Nursing research and practice·2026
Same author

Using Citizen Science to Address Out-of-Pocket Healthcare Expenditure with Aboriginal Communities in the Far West of South Australia: A Protocol.

International journal of environmental research and public health·2025

相关实验视频

Updated: May 13, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

138

数字健康干预措施预防2型糖尿病:系统审查

Tuan Duong1,2, Quita Olsen1, Anish Menon1,3

  • 1Queensland Digital Health Centre, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Journal of medical Internet research
|April 25, 2025
PubMed
概括

数字健康干预 (DHIs) 在2型糖尿病 (T2DM) 管理中显示出对人口健康的好处. 将DHI与医疗保健提供者的相互作用结合起来,是预防T2DM和改善血糖控制的关键.

关键词:
普里斯马是什么意思 普里斯马是什么意思数字健康数字健康数字健康干预是数字健康干预.在糖尿病前期,糖尿病前期.防止 防止 防止 防止2 型糖尿病 2 型糖尿病

更多相关视频

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.7K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.7K

相关实验视频

Last Updated: May 13, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

138
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.7K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.7K

科学领域:

  • 数字健康干预措施 数字健康干预措施
  • 2型糖尿病 (T2DM) 的管理
  • 优化医疗保健系统的优化

背景情况:

  • 数字健康干预 (DHIs) 正在改变医疗保健.
  • 四重目标 (人口健康,消费者体验,提供者体验,降低成本) 引导DHI的发展.
  • 在四重目标中,DHI对T2DM负担的影响仍然不清楚.

研究的目的:

  • 系统地审查DHI对T2DM负担的影响.
  • 通过四重目标的透视来评估影响.
  • 确定T2DM预防和管理的有效DHI策略.

主要方法:

  • 搜索了PubMed,Embase,CINAHL,科学网络 (2014年1月至2024年3月). 这是一个很大的问题.
  • 评估的初级结果:T2DM发展,HbA1c,血糖;二级:消费者/供应商的经验,成本.
  • 使用Cochrane RoB 2和ROBINS-I工具对DHI进行了分类和评估.

主要成果:

  • 包括53篇论文;对T2DM发展的证据有限 (1项积极研究).
  • 在43.4%的研究中对失糖症 (血糖) 产生积极影响;消费者经验不同.
  • 缺乏有关提供者经验和医疗保健成本的数据; DHI和HCP互动的结合显示出积极的结果.

结论:

  • 在T2DM中,DHIs显示出对人口健康的好处,但需要对所有四重目标进行全面评估.
  • 消费者体验的结果混杂;提供者体验和成本的数据不足.
  • 结合DHI与HCP相互作用对于有效的T2DM预防和失糖症管理至关重要.